Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
UDP-alpha-D-galactose + BSA-conjugated C6-ceramide
UDP + ?
-
-
-
-
?
UDP-Gal + GA2-FCHASE
?
FCHASE: 6-(fluorescein-5-carboxamido)hexanoic acid succinimidyl ester
-
-
?
UDP-Gal + GalNAcalpha-FCHASE
?
FCHASE: 6-(fluorescein-5-carboxamido)hexanoic acid succinimidyl ester
-
-
?
UDP-Gal + GalNAcbeta-FCHASE
?
FCHASE: 6-(fluorescein-5-carboxamido)hexanoic acid succinimidyl ester
-
-
?
UDP-Gal + GM2-FCHASE
?
FCHASE: 6-(fluorescein-5-carboxamido)hexanoic acid succinimidyl ester
-
-
?
UDP-Gal + IFNalpha2b-[Tn]-FCHASE
?
the galactosylation of human therapeutic protein IFNalpha2b[Tn] with an engineered variant of CgtB clearly demonstrates that a bacterial glycosyltransferase is able to glycosylate a human protein in vitro. FCHASE: 6-(fluorescein-5-carboxamido)hexanoic acid succinimidyl ester
-
-
?
UDP-Gal + lyso-GM2-FCHASE
?
FCHASE: 6-(fluorescein-5-carboxamido)hexanoic acid succinimidyl ester
-
-
?
UDP-galactose + asialo-GM2
UDP + asialo-GM1
-
i.e. Gg3
-
?
UDP-galactose + ganglioside GA2
UDP + ganglioside GA1
UDP-galactose + GD2
UDP + Gd1b
UDP-galactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
UDP-galactose + N-acetyl-Gal-glycosylphosphatidylinositol
UDP + ?
-
-
-
?
UDPgalactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
additional information
?
-
UDP-galactose + ganglioside GA2
UDP + ganglioside GA1
-
-
-
?
UDP-galactose + ganglioside GA2
UDP + ganglioside GA1
i.e. Cer-Glc-Gal-GalNAc
i.e. Cer-Glc-Gal-GalNAc-Gal
?
UDP-galactose + ganglioside GA2
UDP + ganglioside GA1
i.e. Cer-Glc-Gal-GalNAc
i.e. Cer-Glc-Gal-GalNAc-Gal
?
UDP-galactose + GD2
UDP + Gd1b
i.e. Cer-Glc-Gal-(GalNAc)(NeuNAc2)
i.e. Cer-Glc-Gal-(GalNAc-Gal)(NeuNAc2)
?
UDP-galactose + GD2
UDP + Gd1b
i.e. Cer-Glc-Gal-(GalNAc)(NeuNAc2)
i.e. Cer-Glc-Gal-(GalNAc-Gal)(NeuNAc2)
?
UDP-galactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
best acceptor
i.e. GM1 ganglioside or monosialoganglioside
?
UDP-galactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
donor and acceptor specificity, overview
i.e. GM1 ganglioside or monosialoganglioside
?
UDP-galactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
i.e. GM2 or Tay-Sachs ganglioside
i.e. GM1 ganglioside or monosialoganglioside
?
UDP-galactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
-
-
?
UDP-galactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
donor and acceptor specificity, overview
-
?
UDP-galactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
best acceptor
-
?
UDP-galactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
i.e. GM1
?
UDP-galactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
i.e. GM1
?
UDP-galactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
-
-
?
UDP-galactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
-
-
?
UDP-galactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
-
-
?
UDP-galactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
-
-
?
UDP-galactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
-
-
?
UDP-galactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
-
-
-
?
UDP-galactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
-
i.e. GM1 ganglioside or monosialoganglioside
?
UDP-galactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
best acceptor
i.e. GM1 ganglioside or monosialoganglioside
?
UDP-galactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
donor and acceptor specificity, overview
i.e. GM1 ganglioside or monosialoganglioside
?
UDP-galactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
i.e. GM2 or Tay-Sachs ganglioside
i.e. GM1 ganglioside or monosialoganglioside
?
UDP-galactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
donor and acceptor specificity, overview
i.e. GM1 ganglioside or monosialoganglioside
?
UDP-galactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
-
-
?
UDP-galactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
best acceptor
i.e. GM1 ganglioside or monosialoganglioside
?
UDP-galactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
i.e. GM2 or Tay-Sachs ganglioside
i.e. GM1 ganglioside or monosialoganglioside
?
UDPgalactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
key enzyme in the biosynthesis of the oligodendrocyte- and myelin-specific cerebrosides
-
?
UDPgalactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
involved in biosynthesis of gangliosides
i.e. GM1
?
UDPgalactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
involved in biosynthesis of gangliosides
i.e. GM1
?
UDPgalactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
-
-
-
?
UDPgalactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
key enzyme in the biosynthesis of the oligodendrocyte- and myelin-specific cerebrosides
-
-
?
UDPgalactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
involved in biosynthesis of gangliosides
-
-
?
UDPgalactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
key enzyme in the biosynthesis of the oligodendrocyte- and myelin-specific cerebrosides
-
-
?
additional information
?
-
-
N-acetylgalactosamine and p-nitrophenyl-N-acetylgalactosamine are no substrates
-
-
?
additional information
?
-
GM1 ganglioside synthase B3GALT4 additionally functions in transferring galactose to the N-acetylgalactosamine side-chain of GPI. B3GALT4 requires lactosylceramide for the efficient GPI side-chain galactosylation
-
-
-
additional information
?
-
-
mice heterozygous for a non-functional allele of UDPgalactose:ceramide-galactosyltransferase show decreased synthesis of galactosylceramide and sulfatide, which should reduce sulfatide storage and improve pathology in arylsulfatase A-deficient mice. The phenotypic and pathologic improvements in ASA-/- CGT+/- mice are significant but overall minor
-
-
?
additional information
?
-
-
no substrates are GM3, GM1, GD1a and GT1 gangliosides, glucocerebroside, lactosylceramide, trihexosylceramide
-
-
?
additional information
?
-
-
UDPgalactose:ceramide galactosyltransferase activity does not limit total galactosylceramide level. Tight control of UDP-galactose:ceramide galactosyltransferase expression is essential for myelin maintenance
-
-
?
additional information
?
-
-
no substrates are GM3, GM1, GD1a and GT1 gangliosides, glucocerebroside, lactosylceramide, trihexosylceramide
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
UDP-galactose + asialo-GM2
UDP + asialo-GM1
-
i.e. Gg3
-
?
UDP-galactose + ganglioside GA2
UDP + ganglioside GA1
UDP-galactose + GD2
UDP + Gd1b
UDPgalactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
additional information
?
-
UDP-galactose + ganglioside GA2
UDP + ganglioside GA1
i.e. Cer-Glc-Gal-GalNAc
i.e. Cer-Glc-Gal-GalNAc-Gal
?
UDP-galactose + ganglioside GA2
UDP + ganglioside GA1
i.e. Cer-Glc-Gal-GalNAc
i.e. Cer-Glc-Gal-GalNAc-Gal
?
UDP-galactose + GD2
UDP + Gd1b
i.e. Cer-Glc-Gal-(GalNAc)(NeuNAc2)
i.e. Cer-Glc-Gal-(GalNAc-Gal)(NeuNAc2)
?
UDP-galactose + GD2
UDP + Gd1b
i.e. Cer-Glc-Gal-(GalNAc)(NeuNAc2)
i.e. Cer-Glc-Gal-(GalNAc-Gal)(NeuNAc2)
?
UDPgalactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
key enzyme in the biosynthesis of the oligodendrocyte- and myelin-specific cerebrosides
-
?
UDPgalactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
involved in biosynthesis of gangliosides
i.e. GM1
?
UDPgalactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
involved in biosynthesis of gangliosides
i.e. GM1
?
UDPgalactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
-
-
-
?
UDPgalactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
key enzyme in the biosynthesis of the oligodendrocyte- and myelin-specific cerebrosides
-
-
?
UDPgalactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
involved in biosynthesis of gangliosides
-
-
?
UDPgalactose + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine
UDP + D-galactosyl-1,3-beta-N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine
-
key enzyme in the biosynthesis of the oligodendrocyte- and myelin-specific cerebrosides
-
-
?
additional information
?
-
-
mice heterozygous for a non-functional allele of UDPgalactose:ceramide-galactosyltransferase show decreased synthesis of galactosylceramide and sulfatide, which should reduce sulfatide storage and improve pathology in arylsulfatase A-deficient mice. The phenotypic and pathologic improvements in ASA-/- CGT+/- mice are significant but overall minor
-
-
?
additional information
?
-
-
UDPgalactose:ceramide galactosyltransferase activity does not limit total galactosylceramide level. Tight control of UDP-galactose:ceramide galactosyltransferase expression is essential for myelin maintenance
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Adenoma
Ceramide galactosyltransferase (UGT8) as a molecular marker of canine mammary tumor malignancy.
Alzheimer Disease
DNA Hypomethylation in Blood Links B3GALT4 and ZADH2 to Alzheimer's Disease.
Breast Neoplasms
Ceramide galactosyltransferase (UGT8) is a molecular marker of breast cancer malignancy and lung metastases.
Breast Neoplasms
Galactosylceramide affects tumorigenic and metastatic properties of breast cancer cells as an anti-apoptotic molecule.
Breast Neoplasms
Molecular basis of incomplete O-glycan synthesis in MCF-7 breast cancer cells: putative role of MUC6 in Tn antigen expression.
Carcinoma
Benzyl-N-acetyl-alpha-D-galactosaminide inhibits the sialylation and the secretion of mucins by a mucin secreting HT-29 cell subpopulation.
Carcinoma
Ceramide galactosyltransferase (UGT8) as a molecular marker of canine mammary tumor malignancy.
Cholestasis
Changes in GM1 ganglioside content and localization in cholestatic rat liver.
Colonic Neoplasms
beta 1,3-Galactosyltransferase beta 3Gal-T5 acts on the GlcNAcbeta 1-->3Galbeta 1-->4GlcNAcbeta 1-->R sugar chains of carcinoembryonic antigen and other N-linked glycoproteins and is down-regulated in colon adenocarcinomas.
Colorectal Neoplasms
Clinical correlation of B7-H3 and B3GALT4 with the prognosis of colorectal cancer.
Demyelinating Diseases
Reversal of non-hydroxy:alpha-hydroxy galactosylceramide ratio and unstable myelin in transgenic mice overexpressing UDP-galactose:ceramide galactosyltransferase.
Leukodystrophy, Globoid Cell
Glycosylceramide synthesis in the developing spinal cord and kidney of the twitcher mouse, an enzymatically authentic model of human Krabbe disease.
Neoplasm Metastasis
Ceramide galactosyltransferase (UGT8) is a molecular marker of breast cancer malignancy and lung metastases.
Neoplasm Metastasis
Galactosylceramide affects tumorigenic and metastatic properties of breast cancer cells as an anti-apoptotic molecule.
Neoplasms
Benzyl-N-acetyl-alpha-D-galactosaminide inhibits the sialylation and the secretion of mucins by a mucin secreting HT-29 cell subpopulation.
Neoplasms
Galactosylceramide affects tumorigenic and metastatic properties of breast cancer cells as an anti-apoptotic molecule.
Pancreatic Neoplasms
Association between expression levels of CA 19-9 and N-acetylglucosamine-beta;1,3-galactosyltransferase 5 gene in human pancreatic cancer tissue.
Paralysis
Reversal of non-hydroxy:alpha-hydroxy galactosylceramide ratio and unstable myelin in transgenic mice overexpressing UDP-galactose:ceramide galactosyltransferase.
Sarcoma
Absence of a specific ganglioside galactosyltransferase in mouse cells transformed by murine sarcoma virus.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.00000005
recombinant enzyme, crude cell homogenate of transfected NIH 3T3 cells
0.000000051
recombinant enzyme, crude cell homogenate of transfected CHO-K1 cells
0.00000007
recombinant enzyme, crude cell homogenate of transfected CHO-K1 cells
0.00000009
testis, crude homogenate, native wild-type
additional information
relative activity: GalNAcalpha: 1.4%, GalNAcbeta: 1.9%, GM2: 38%, lyso-GM2: 0.3%, GA2: 100%
additional information
relative activity: GalNAcalpha: 1.4%, GalNAcbeta: 1.9%, GM2: 38%, lyso-GM2: 0.3%, GA2: 100%
additional information
relative activity: GalNAcalpha: 1.4%, GalNAcbeta: 1.9%, GM2: 38%, lyso-GM2: 0.3%, GA2: 100%
additional information
-
relative activity: GalNAcalpha: 1.4%, GalNAcbeta: 1.9%, GM2: 38%, lyso-GM2: 0.3%, GA2: 100%
additional information
relative activity: GalNAcalpha: 3.0%, GalNAcbeta: 50.5%, GM2: 100%, lyso-GM2: 606%, GA2: 8.8%
additional information
relative activity: GalNAcalpha: 3.0%, GalNAcbeta: 50.5%, GM2: 100%, lyso-GM2: 606%, GA2: 8.8%
additional information
relative activity: GalNAcalpha: 3.0%, GalNAcbeta: 50.5%, GM2: 100%, lyso-GM2: 606%, GA2: 8.8%
additional information
-
relative activity: GalNAcalpha: 3.0%, GalNAcbeta: 50.5%, GM2: 100%, lyso-GM2: 606%, GA2: 8.8%
additional information
relative activity: GalNAcalpha: 6.4%, GalNAcbeta: 47.5%, GM2: 100%, lyso-GM2: 444%, GA2: 29%
additional information
relative activity: GalNAcalpha: 6.4%, GalNAcbeta: 47.5%, GM2: 100%, lyso-GM2: 444%, GA2: 29%
additional information
relative activity: GalNAcalpha: 6.4%, GalNAcbeta: 47.5%, GM2: 100%, lyso-GM2: 444%, GA2: 29%
additional information
-
relative activity: GalNAcalpha: 6.4%, GalNAcbeta: 47.5%, GM2: 100%, lyso-GM2: 444%, GA2: 29%
additional information
specific activity of N-term MalE-CgtBOH4384 fusion construct (mU/mg): 158 (substrate: GalNAcalpha), 192 (substrate: GalNAcbeta), 210 (substrate: GM2), 83.5 (substrate: IFNalpha2b)
additional information
specific activity of N-term MalE-CgtBOH4384 fusion construct (mU/mg): 158 (substrate: GalNAcalpha), 192 (substrate: GalNAcbeta), 210 (substrate: GM2), 83.5 (substrate: IFNalpha2b)
additional information
specific activity of N-term MalE-CgtBOH4384 fusion construct (mU/mg): 158 (substrate: GalNAcalpha), 192 (substrate: GalNAcbeta), 210 (substrate: GM2), 83.5 (substrate: IFNalpha2b)
additional information
-
specific activity of N-term MalE-CgtBOH4384 fusion construct (mU/mg): 158 (substrate: GalNAcalpha), 192 (substrate: GalNAcbeta), 210 (substrate: GM2), 83.5 (substrate: IFNalpha2b)
additional information
specific activity of N-term MalE-CgtBOH4384 fusion construct (mU/mg): 9.7 (substrate: GalNAcalpha), 4.8 (substrate: GalNAcbeta), 4.5 (substrate: GM2), 86.9 (substrate: GA2)
additional information
specific activity of N-term MalE-CgtBOH4384 fusion construct (mU/mg): 9.7 (substrate: GalNAcalpha), 4.8 (substrate: GalNAcbeta), 4.5 (substrate: GM2), 86.9 (substrate: GA2)
additional information
specific activity of N-term MalE-CgtBOH4384 fusion construct (mU/mg): 9.7 (substrate: GalNAcalpha), 4.8 (substrate: GalNAcbeta), 4.5 (substrate: GM2), 86.9 (substrate: GA2)
additional information
-
specific activity of N-term MalE-CgtBOH4384 fusion construct (mU/mg): 9.7 (substrate: GalNAcalpha), 4.8 (substrate: GalNAcbeta), 4.5 (substrate: GM2), 86.9 (substrate: GA2)
additional information
specific activity of N-term MalECgtBOH4384 fusion construct (mU/mg): 13.6 (substrate: GalNAcalpha), 40.4 (substrate: GalNAcbeta), 27 (substrate: GM2)
additional information
specific activity of N-term MalECgtBOH4384 fusion construct (mU/mg): 13.6 (substrate: GalNAcalpha), 40.4 (substrate: GalNAcbeta), 27 (substrate: GM2)
additional information
specific activity of N-term MalECgtBOH4384 fusion construct (mU/mg): 13.6 (substrate: GalNAcalpha), 40.4 (substrate: GalNAcbeta), 27 (substrate: GM2)
additional information
-
specific activity of N-term MalECgtBOH4384 fusion construct (mU/mg): 13.6 (substrate: GalNAcalpha), 40.4 (substrate: GalNAcbeta), 27 (substrate: GM2)
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Tencomnao, T.; Yu, R.K.; Kapitonov, D.
Characterization of the human UDP-galactose:ceramide galactosyltransferase gene promoter
Biochim. Biophys. Acta
1517
416-423
2001
Homo sapiens
brenda
Schulte, S.; Stoffel, W.
UDP galactose:ceramide galactosyltransferase and glutamate/aspartate transporter. Copurification, separation and characterization of the two glycoproteins
Eur. J. Biochem.
233
947-953
1995
Rattus norvegicus, Rattus norvegicus Wistar
brenda
Sanyal, S.N.
Stimulation of uridine diphosphate-galactose: ceramide galactosyl transferase by certain soluble protein factor in rat brain cytosol
Indian J. Exp. Biol.
25
606-612
1987
Rattus norvegicus
brenda
Neskovic, N.M.; Mandel, P.; Gatt, S.
UDP-galactose: ceramide galactosyltransferase. Kinetic properties and effect of detergents and phospholipids on the partially purified enzyme of rat brain
Adv. Exp. Med. Biol.
101
613-630
1978
Rattus norvegicus
brenda
Basu, S.; Kaufman, B.; Roseman, S.
Conversion of Tay-Sachs ganglioside to monosialoganglioside by brain uridine diphosphate D-galactose: glycolipid galactosyltransferase
J. Biol. Chem.
240
4115-4117
1965
Gallus gallus, Rattus norvegicus, Sus scrofa
brenda
Yip, M.C.M.; Dain, J.A.
Frog brain uridine diphosphate galactose-N-acetylgalactosaminyl-N-acetylneuraminylgalactosylglucosylceramide galactosyltransferase
Biochem. J.
118
247-252
1970
Lithobates pipiens
brenda
Bellman Yip, G.; Dain, J.A.
The enzymic synthesis of ganglioside. II. UDP-galactose: N-acetylgalactosaminyl-(N-acetylneuraminyl)galactosyl-glucosyl-ceramide galactosyltransferase in rat brain
Biochim. Biophys. Acta
206
252-260
1970
Rattus norvegicus, Rattus norvegicus Sprague-Dawley
brenda
Senn, H.J.; Wagner, M.; Decker, K.
Ganglioside biosynthesis in rat liver. Characterization of UDPgalactose--glucosylceramide galactosyltransferase and UDPgalactose-GM2 galactosyltransferase
Eur. J. Biochem.
135
231-236
1983
Rattus norvegicus
brenda
Costantino-Ceccarini, E.; Suzuki, K.
Isolation and partial characterization of an endogenous inhibitor of ceramide glycosyltransferases from rat brain
J. Biol. Chem.
253
340-342
1978
Rattus norvegicus
brenda
Stahl, N.; Jurevics, H.; Morell, P.; Suzuki, K.; Popko, B.
Isolation, characterization, and expression of cDNA clones that encode rat UDP-galactose:ceramide galactosyltransferase
J. Neurosci. Res.
38
234-242
1994
Rattus norvegicus
brenda
Ghosh, S.; Kyle, J.W.; Dastgheib, S.; Daussin, F.; Li, Z.; Basu, S.
Purification, properties, and immunological characterization of GalT-3 (UDP-galactose: GM2 ganglioside, beta1-3 galactosyltransferase) from embryonic chicken brain
Glycoconjugate J.
12
838-847
1995
Gallus gallus
brenda
Sprong, H.; Kruithof, B.; Leijendekker, R.; Slot, J.W.; Van Meer, G.; Van Der Sluijs, P.
UDP-galactose:ceramide galactosyltransferase is a class I integral membrane protein of the endoplasmic reticulum
J. Biol. Chem.
273
25880-25888
1998
no activity in Mesocricetus auratus, Rattus norvegicus
brenda
Amado, M.; Almeida, R.; Carneiro, F.; Levery, S.B.; Holmes, E.H.; Nomoto, M.; Hollingsworth, M.A.; Hassan, H.; Schwientek, T.; Nielsen, P.A.; Bennett, E.P.; Clausen, H.
A family of human beta3-galactosyltransferases. Characterization of four members of a UDP-galactose:beta-N-acetyl-glucosamine/beta-acetyl-galactosamine beta-1,3-galactosyltransferase family
J. Biol. Chem.
273
12770-12778
1998
Homo sapiens (O43825), Homo sapiens (O75752), Homo sapiens (O96024), Drosophila melanogaster (Q24157)
brenda
Daniotti, J.L.; Martina, J.A.; Zurita, A.R.; Maccioni, H.J.
Mouse beta 1,3-galactosyltransferase (GA1/GM1/GD1b synthase): protein characterization, tissue expression, and developmental regulation in neural retina
J. Neurosci. Res.
58
318-327
1999
Mus musculus (Q9Z0F0), Mus musculus
brenda
Martina, J.A.; Daniotti, J.L.; Maccioni, H.J.
GM1 synthase depends on N-glycosylation for enzyme activity and trafficking to the Golgi complex
Neurochem. Res.
25
725-731
2000
Mus musculus (Q9Z0F0), Mus musculus
brenda
Paul, P.; Lutz, T.M.; Osborn, C.; Kyosseva, S.; Elbein, A.D.; Towbin, H.; Radominska, A.; Drake, R.R.
Synthesis and characterization of a new class of inhibitors of membrane-associated UDP-glycosyltransferases
J. Biol. Chem.
268
12933-12938
1993
Mus musculus
brenda
Fewou, S.N.; Bussow, H.; Schaeren-Wiemers, N.; Vanier, M.T.; Macklin, W.B.; Gieselmann, V.; Eckhardt, M.
Reversal of non-hydroxy:alpha-hydroxy galactosylceramide ratio and unstable myelin in transgenic mice overexpressing UDP-galactose:ceramide galactosyltransferase
J. Neurochem.
94
469-481
2005
Rattus norvegicus
brenda
Franken, S.; Wittke, D.; Mansson, J.E.; DHooge, R.; De Deyn, P.P.; Luellmann-Rauch, R.; Matzner, U.; Gieselmann, V.
Modest phenotypic improvements in ASA-deficient mice with only one UDP-galactose:ceramide-galactosyltransferase gene
Lipids Health Dis.
5
21
2006
Mus musculus
brenda
Bernatchez, S.; Gilbert, M.; Blanchard, M.C.; Karwaski, M.F.; Li, J.; Defrees, S.; Wakarchuk, W.W.
Variants of the beta 1,3-galactosyltransferase CgtB from the bacterium Campylobacter jejuni have distinct acceptor specificities
Glycobiology
17
1333-1343
2007
Campylobacter jejuni (Q0P9B5), Campylobacter jejuni (Q93MQ1), Campylobacter jejuni (Q9K2V8), Campylobacter jejuni
brenda
Saadat, L.; Dupree, J.L.; Kilkus, J.; Han, X.; Traka, M.; Proia, R.L.; Dawson, G.; Popko, B.
Absence of oligodendroglial glucosylceramide synthesis does not result in CNS myelin abnormalities or alter the dysmyelinating phenotype of CGT-deficient mice
Glia
58
391-398
2010
Mus musculus
brenda
Niimura, Y.; Moue, T.; Takahashi, N.; Nagai, K.I.
Modification of sphingoglycolipids and sulfolipids in kidney cell lines under heat stress: Activation of monohexosylceramide synthesis as a ceramide scavenger
Glycobiology
20
710-717
2010
Chlorocebus aethiops, Canis lupus familiaris
brenda
Dziegiel, P.; Owczarek, T.; Plazuk, E.; Gomulkiewicz, A.; Majchrzak, M.; Podhorska-Okolow, M.; Driouch, K.; Lidereau, R.; Ugorski, M.
Ceramide galactosyltransferase (UGT8) is a molecular marker of breast cancer malignancy and lung metastases
Br. J. Cancer
103
524-531
2010
Homo sapiens
brenda
Hayashi, T.; Hayashi, E.; Fujimoto, M.; Sprong, H.; Su, T.P.
The lifetime of UDP-galactose:ceramide galactosyltransferase is controlled by a distinct endoplasmic reticulum-associated degradation (ERAD) regulated by sigma-1 receptor chaperones
J. Biol. Chem.
287
43156-43169
2012
Rattus norvegicus
brenda
Wang, Y.; Maeda, Y.; Liu, Y.S.; Takada, Y.; Ninomiya, A.; Hirata, T.; Fujita, M.; Murakami, Y.; Kinoshita, T.
Cross-talks of glycosylphosphatidylinositol biosynthesis with glycosphingolipid biosynthesis and ER-associated degradation
Nat. Commun.
11
860
2020
Homo sapiens (O96024)
brenda